< Back to the Blog

About the author

Amy Divaraniya
Dr. Aparna (Amy) Divaraniya is the Founder and CEO of Oova. She has over 10 years experience working in data science and a PhD in Biomedical Sciences. In 2017, Amy pivoted to women's healthcare after facing her own fertility struggles. Amy started Oova to give women control over their fertility by making high-quality hormone testing more accessible.

Sources

  1. Direito A, et al. "Relationships between the luteinizing hormone surge and other characteristics of the menstrual cycle in normally ovulating women." Fertility and Sterility. 2013.
  2. Guermandi E, et al. "Reliability of ovulation tests in infertile women." Obstetrics & Gynecology. 2001;97(1):92–96.
  3. Prior JC. "Progesterone for Symptomatic Perimenopause Treatment." Journal of Obstetrics and Gynaecology Canada. 2011.
  4. Nasseri S, Ledger WL. "Clomiphene citrate in the twenty-first century." Human Fertility. 2001.
  5. Holden EC, et al. "Ultrasound versus urinary LH surge for trigger timing in IUI cycles." Fertility and Sterility. 2020.
  6. Su HW, et al. "Detection of ovulation, a review of currently available methods." Bioengineering & Translational Medicine. 2017;2(3):238–246.

About the Oova Blog:
Our content is developed with a commitment to high editorial standards and reliability. We prioritize referencing reputable sources and sharing where our insights come from. The Oova Blog is intended for informational purposes only and is never a substitute for professional medical advice. Always consult a healthcare provider before making any health decisions.